Our Focus

BioQuest offers a strong portfolio of highly promising, advanced, innovative medical products and technologies aimed at large, growing markets with unmet medical needs, all of which are available for licensing and/or acquisition.

We create opportunities by finding, selecting and investing in new medical innovations where we can apply our expertise and support to virtually manage and accelerate their successful development. We minimize infrastructure requirements and have a strong track record of realizing exceptional returns for our investors.

If you would like to discuss any of our potential investment opportunities, please call us or send us an email. We’d be pleased to provide you with more detail or answer any questions that you may have.

Advantages

We provide investors, licensees, and pharmaceutical and biotech companies with several strong advantages:

• Promising technologies
  BioQuest’s highly experienced team provides identification, screening and advanced development of highly promising early-stage research in new medical technologies aimed at large markets with unmet medical needs.
• Added value
  BioQuest is product focused, rapidly creating and moving products into and through the clinic to accelerate value creation. We ensure that key studies meet all GxP standards so that downstream partners can focus on the path forward.
• Clean companies
  BioQuest companies are backed by a strong team of experienced negotiators and supportive investors that can be relied upon to ease the process during licensing or acquisition negotiations.
• Secure intellectual property estates
  BioQuest provides thorough, reliable management of all intellectual property.
• Significant return on investment
  BioQuest’s team provides an outstanding blend of commercial and scientific expertise to accelerate development timelines while minimizing infrastructure requirements for maximum return on investment.

Opportunities and Services

BioQuest offers offers unique and attractive opportunities for investors, licensees, and pharmaceutical and biotech companies. BioQuest has access to innovative medical technologies with strong commercial opportunities developed at leading universities, research institutions and biotechnology companies. BioQuest employs a rigorous screening and evaluation process, and selects only the most promising investments from a large choice of new opportunities to help streamline product development and accelerate commercialization.

Out-licensing programs
BioQuest out-licenses programs to suitable biotechnology and pharmaceutical companies, which then manage the remaining clinical development required to obtain final regulatory approval for the products licensed. Many of the products in BioQuest’s portfolio are available for out-licensing proposals. If you would like to discuss any of BioQuest’s out-licensing opportunities, please contact us.

Acquisitions
As an alternative to license agreements, many of the companies in BioQuest’s are also available for acquisition by a suitable pharmaceutical or biotechnology company. BioQuest’s virtual development model makes these companies very attractive for acquisition, as there is no infrastructure and little or no overhead that would need to be absorbed by the acquirer. If you would like to discuss any of our acquisition opportunities, please contact us.